Hyperaldosteronism natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
{{ | {{PleaseHelp}} | ||
==Overview== | ==Overview== | ||
Line 15: | Line 15: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Endocrinology]] | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category: | [[Category:Needs overview]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
Latest revision as of 19:55, 26 July 2016
Hyperaldosteronism Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
The prognosis for primary hyperaldosteronism is good with early diagnosis and treatment. The prognosis for secondary hyperaldosteronism will vary depending on the cause of the condition. Impotence and gynecomastia (enlarged breasts in men) may occur with long-term spironolactone treatment in men, but this is uncommon.